A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/06 (2006.01) A61K 9/08 (2006.01) A61K 9/12 (2006.01) A61K 47/10 (2006.01) A61K 47/14 (2006.01) A61P 5/00 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2704117
A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
Cette invention concerne un système d'administration transdermique comprenant une composition qui contient un agent à activité physiologique et un activateur de pénétration, lequel activateur de pénétration comprend une combinaison (i) d'un ester d'acide salicylique, de préférence choisi à parmi les esters aliphatiques C6 à C30 de l'acide salicylique et ii) de polyéthylène glycol (PEG) présentant un poids moléculaire moyen égal ou inférieur à 300.
Setiawan Kerrie
Watkinson Adam
Acrux Dds Pty. Ltd.
Kirby Eades Gale Baker
LandOfFree
Transdermal delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1665002